The Belfast City Hospital in Belfast, Northern Ireland, is a 900-bed modern university teaching hospital providing local acute services and key regional specialities. Its distinctive orange tower block dominates the Belfast skyline being the third tallest storeyed building in Ireland.

There are 900 beds in Belfast City Hospital.

During the past decade, Belfast City Hospital conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 26 clinical trials were completed, i.e. on average, 36.1% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 17 clinical trials were completed. i.e. 63% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Belfast City Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 10 trials, followed by "University College, London" with 7 trials sponsored, "University of Birmingham" with 5 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 105 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Belfast City Hospital" #1 collaborator was "Cancer Research UK" with 8 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "Cystic Fibrosis Foundation" with 4 trials as a collaborator, "Celgene" with 3 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 3 trials as a collaborator. Other collaborators include 103 different institutions and companies that were collaborators in the rest 100 trials.

According to Clinical.Site data, the most researched conditions in "Belfast City Hospital" are "Cystic Fibrosis" (12 trials), "Breast Cancer" (10 trials), "Asthma" (5 trials), "Advanced Solid Tumors" (4 trials) and "Bronchiectasis" (4 trials). Many other conditions were trialed in "Belfast City Hospital" in a lesser frequency.

Most popular intervention types in "Belfast City Hospital" are "Drug" (108 trials), "Other" (23 trials), "Radiation" (16 trials), "Procedure" (12 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "radiation therapy" (6 trials), "Carboplatin" (4 trials), "Cisplatin" (4 trials) and "fluorouracil" (4 trials). Other intervention names were less common.

The vast majority of trials in "Belfast City Hospital" are 114 trials for "All" genders, 17 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Belfast City Hospital". 1 are not yet recruiting, 21 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 75 completed trials in Belfast City Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Belfast City Hospital, 18 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 18 trials that are defined as “Not Applicable".

Belfast City Hospital has several departments that took part in Clinical trials: "Craigavon Cardiac Centre" - 7 trials, "Royal Belfast Hospital for Sick Children" - 58 trials, "Department of Rheumatology, Altnagelvin Hospital" - 3 trials, "Belfast City Hospital Haematology Department" - 2 trials, "Northern Ireland Cancer Centre" - 2 trials